Medical Science Liaison, Rare Diseases — US Field

Amgen Inc.; Virginia Beach (VA); Hybrid; USD 157,000 - 212,000; Full time

Benefits offered by this job

Total Rewards Plan

Stock-based incentives

Flexible work models

Job summary

Amgen Inc. seeks a Medical Science Liaison (MSL) for Rare Disease-GPA/MPA & Sjögren’s Disease in the VA/WV/Eastern Kentucky region.

The MSL serves as the primary scientific resource to opinion leaders and health care providers, executing Amgen’s medical strategy and ensuring balanced, compliant data exchange to improve patient outcomes. Responsibilities include peer-to-peer interactions, cross-functional collaboration, and field-based support for research and speaker training.

Qualifications

• Doctorate degree OR Master’s degree with 3 years Medical Affairs experience OR Bachelor’s degree with 5 years Medical Affairs experience.
• Proven ability to communicate scientific information to diverse audiences.
• Strong relationships with external stakeholders and internal teams.

Responsibilities

• Provide scientific exchange with OLs, PHDMs and health care providers to advance Amgen’s platform.
• Collaborate across Amgen field roles to deliver a coordinated One Amgen experience.
• Maintain clinical/scientific acumen with current data and trends; support sponsored research and investigator-initiated studies.

Skills

Scientific communication

Relationship building

Data interpretation

Cross-functional collaboration

Education

Doctorate degree

Master’s degree

Bachelor’s degree

Tools

Veeva CRM

Job description

Amgen Inc. seeks a Medical Science Liaison (MSL) for Rare Disease-GPA/MPA & Sjögren’s Disease in the VA/WV/Eastern Kentucky region.

The MSL serves as the primary scientific resource to opinion leaders and health care providers, executing Amgen’s medical strategy and ensuring balanced, compliant data exchange to improve patient outcomes. Responsibilities include peer-to-peer interactions, cross-functional collaboration, and field-based support for research and speaker training.